Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobey MacDonald

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Cell|June 13, 2018
BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated DegradationDan Zhu, Satoru Osuka, Zhaobin Zhang, et al.
Neuro-Oncology|February 15, 2020
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conferenceRoger J Packer, Antonio Iavarone, David T W Jones, et al.
Neuro-Oncology|February 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant gliomaYazmin Odia, Carl Koschmann, Nicholas A Vitanza, et al.
Acta Neuropathologica|February 19, 2015
Medulloblastoma subgroups remain stable across primary and metastatic compartmentsXin Wang, Adrian M Dubuc, Vijay Ramaswamy, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Cell|June 13, 2018
BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated DegradationDan Zhu, Satoru Osuka, Zhaobin Zhang, et al.
Neuro-Oncology|February 15, 2020
Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conferenceRoger J Packer, Antonio Iavarone, David T W Jones, et al.
Neuro-Oncology|February 24, 2024
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant gliomaYazmin Odia, Carl Koschmann, Nicholas A Vitanza, et al.
Acta Neuropathologica|February 19, 2015
Medulloblastoma subgroups remain stable across primary and metastatic compartmentsXin Wang, Adrian M Dubuc, Vijay Ramaswamy, et al.
Pageof 3